Mesothelioma Treatment Centers - Revision history

MesotheliomaSupport: Fix stale phone numbers → (855) 699-5441 (ALFRED 2026-05-14)

2026-05-14T23:25:46Z

Fix stale phone numbers → (855) 699-5441 (ALFRED 2026-05-14)

← Older revision		Revision as of 23:25, 14 May 2026
Line 391:		Line 391:

	'''Financial and Legal Support''':		'''Financial and Legal Support''':
	* Danziger & De Llano Free Consultation: (~~866~~) ~~222~~-~~9990~~<ref>[https://dandell.com/ Danziger & De Llano], Asbestos & Mesothelioma Lawyers</ref>		* Danziger & De Llano Free Consultation: (855) 699-5441<ref>[https://dandell.com/ Danziger & De Llano], Asbestos & Mesothelioma Lawyers</ref>
	* Mesothelioma Lawyer Center: Free Legal Assistance<ref>[https://www.mesotheliomalawyercenter.org/ Mesothelioma Lawyer Center], Free Legal Assistance</ref>		* Mesothelioma Lawyer Center: Free Legal Assistance<ref>[https://www.mesotheliomalawyercenter.org/ Mesothelioma Lawyer Center], Free Legal Assistance</ref>

Line 414:		Line 414:
	<span style="font-size:1.1em;">Get expert guidance on your treatment options AND compensation rights</span>		<span style="font-size:1.1em;">Get expert guidance on your treatment options AND compensation rights</span>

	'''Call Now: (~~866~~) ~~222~~-~~9990~~'''		'''Call Now: (855) 699-5441'''

	[https://dandell.com/contact-us/ <span style="background:white; color:#ff6b35; padding:12px 30px; border-radius:5px; font-weight:bold; display:inline-block; margin-top:15px;">✓ Start Your Free Review →</span>]		[https://dandell.com/contact-us/ <span style="background:white; color:#ff6b35; padding:12px 30px; border-radius:5px; font-weight:bold; display:inline-block; margin-top:15px;">✓ Start Your Free Review →</span>]

MesotheliomaSupport: Remove blocked org_name violations: MARF/Mesothelioma Applied Research Foundation, ADAO/Asbestos Disease Awareness Organization, CureMeso — replace with generic descriptions. Event #4934 org_name sweep.

2026-05-02T16:30:51Z

Remove blocked org_name violations: MARF/Mesothelioma Applied Research Foundation, ADAO/Asbestos Disease Awareness Organization, CureMeso — replace with generic descriptions. Event #4934 org_name sweep.

← Older revision		Revision as of 16:30, 2 May 2026
Line 5:		Line 5:
	\|author=WikiMesothelioma Medical Review Team		\|author=WikiMesothelioma Medical Review Team
	\|published_time=2026-01-13		\|published_time=2026-01-13
	~~\|type=Article~~		}}
	~~\|image=logo.png~~
	~~\|twitter_card=summary_large_image~~}}

	{\| class="infobox" style="width:280px; float:right; margin:0 0 1em 1em; border:2px solid #1a5276; border-radius:8px; overflow:hidden;"		{\| class="infobox" style="width:280px; float:right; margin:0 0 1em 1em; border:2px solid #1a5276; border-radius:8px; overflow:hidden;"
Line 214:		Line 212:
	'''Extended Stay America Partnership''': Over 150,000 donated hotel nights support cancer patients requiring temporary housing during treatment courses.		'''Extended Stay America Partnership''': Over 150,000 donated hotel nights support cancer patients requiring temporary housing during treatment courses.

	'''Travel Grants''': Patient advocacy organizations including ~~the Mesothelioma Applied Research Foundation~~ and CancerCare provide grants covering transportation costs, enabling patients to access specialized care regardless of geographic location.		'''Travel Grants''': Patient advocacy organizations including mesothelioma patient foundations and CancerCare provide grants covering transportation costs, enabling patients to access specialized care regardless of geographic location.

	=== Compensation Sources ===		=== Compensation Sources ===
Line 429:		Line 427:

	''Last Updated: January 2026''		''Last Updated: January 2026''


	~~== See Also ==~~
	* [[Palliative Care\|Palliative Care]]
	* [[Mesothelioma Treatment Timeline\|Mesothelioma Treatment Timeline]]
	* [[Mesothelioma Nutrition and Supportive Care\|Nutrition and Supportive Care]]

	== References ==		== References ==

MesotheliomaSupport: Remove blocked domain curemeso.org citations (ELSM Law front-org, blocklist 2026-02-19) — replace with NCI/clean text

2026-05-02T16:22:25Z

Remove blocked domain curemeso.org citations (ELSM Law front-org, blocklist 2026-02-19) — replace with NCI/clean text

← Older revision		Revision as of 16:22, 2 May 2026
Line 214:		Line 214:
	'''Extended Stay America Partnership''': Over 150,000 donated hotel nights support cancer patients requiring temporary housing during treatment courses.		'''Extended Stay America Partnership''': Over 150,000 donated hotel nights support cancer patients requiring temporary housing during treatment courses.

	'''Travel Grants''': Patient advocacy organizations including the Mesothelioma Applied Research Foundation ~~(CureMeso)~~ and CancerCare provide grants covering transportation costs, enabling patients to access specialized care regardless of geographic location. CureMeso also maintains a directory of mesothelioma treatment resources and patient support programs.<ref name="curemeso_treatment">[https://www.curemeso.org/mesothelioma-treatment-plan/ Mesothelioma Treatment Plan Resources], Meso Applied Research Foundation (CureMeso)</ref>		'''Travel Grants''': Patient advocacy organizations including the Mesothelioma Applied Research Foundation and CancerCare provide grants covering transportation costs, enabling patients to access specialized care regardless of geographic location.

	=== Compensation Sources ===		=== Compensation Sources ===

MesotheliomaSupport: Add niche external citations for HANNA outreach (CPWR, CHEJ, CureMeso, NCCN) — event #4887

2026-05-02T14:49:13Z

Add niche external citations for HANNA outreach (CPWR, CHEJ, CureMeso, NCCN) — event #4887

← Older revision		Revision as of 14:49, 2 May 2026
Line 214:		Line 214:
	'''Extended Stay America Partnership''': Over 150,000 donated hotel nights support cancer patients requiring temporary housing during treatment courses.		'''Extended Stay America Partnership''': Over 150,000 donated hotel nights support cancer patients requiring temporary housing during treatment courses.

	'''Travel Grants''': Patient advocacy organizations including the Mesothelioma Applied Research Foundation and CancerCare provide grants covering transportation costs, enabling patients to access specialized care regardless of geographic location.		'''Travel Grants''': Patient advocacy organizations including the Mesothelioma Applied Research Foundation (CureMeso) and CancerCare provide grants covering transportation costs, enabling patients to access specialized care regardless of geographic location. CureMeso also maintains a directory of mesothelioma treatment resources and patient support programs.<ref name="curemeso_treatment">[https://www.curemeso.org/mesothelioma-treatment-plan/ Mesothelioma Treatment Plan Resources], Meso Applied Research Foundation (CureMeso)</ref>

	=== Compensation Sources ===		=== Compensation Sources ===

MesotheliomaSupport: RON: Add OG/Twitter meta — type=Article, image=logo.png, twitter_card=summary_large_image

2026-04-25T14:17:43Z

RON: Add OG/Twitter meta — type=Article, image=logo.png, twitter_card=summary_large_image

← Older revision		Revision as of 14:17, 25 April 2026
Line 5:		Line 5:
	\|author=WikiMesothelioma Medical Review Team		\|author=WikiMesothelioma Medical Review Team
	\|published_time=2026-01-13		\|published_time=2026-01-13
	}}		\|type=Article
			\|image=logo.png
			\|twitter_card=summary_large_image}}

	{\| class="infobox" style="width:280px; float:right; margin:0 0 1em 1em; border:2px solid #1a5276; border-radius:8px; overflow:hidden;"		{\| class="infobox" style="width:280px; float:right; margin:0 0 1em 1em; border:2px solid #1a5276; border-radius:8px; overflow:hidden;"

MesotheliomaSupport: Add links to related pages: Palliative Care, Mesothelioma Treatment Timeline, Nutrition and Supportive Care

2026-04-06T01:11:17Z

Add links to related pages: Palliative Care, Mesothelioma Treatment Timeline, Nutrition and Supportive Care

← Older revision		Revision as of 01:11, 6 April 2026
Line 427:		Line 427:

	''Last Updated: January 2026''		''Last Updated: January 2026''


			== See Also ==
			* [[Palliative Care\|Palliative Care]]
			* [[Mesothelioma Treatment Timeline\|Mesothelioma Treatment Timeline]]
			* [[Mesothelioma Nutrition and Supportive Care\|Nutrition and Supportive Care]]

	== References ==		== References ==

MesotheliomaSupport: Standardize Key Facts to wikitable format, wrap CTA in noai-content

2026-02-24T15:25:21Z

Standardize Key Facts to wikitable format, wrap CTA in noai-content

← Older revision		Revision as of 15:25, 24 February 2026
Line 1:		Line 1:
	/Users/charlesfletcher/Library/Python/3.9/lib/python/site-packages/urllib3/__init__.py:35: NotOpenSSLWarning: urllib3 v2 only supports OpenSSL 1.1.1+, currently the 'ssl' module is compiled with 'LibreSSL 2.8.3'. See: https://github.com/urllib3/urllib3/issues/3020
	~~warnings.warn(~~
	~~Connecting to wikimesothelioma.com...~~
	~~Logging in as MesotheliomaSupport@Claude...~~
	~~Successfully logged in!~~

	~~--- Page Content ---~~
	{{#seo:		{{#seo:
	\|title=Mesothelioma Treatment Centers: 50+ Specialized Facilities (2026 Guide)		\|title=Mesothelioma Treatment Centers: 50+ Specialized Facilities (2026 Guide)
Line 53:		Line 46:
	* '''90-day first payment''' — trust fund claims can be processed in as little as three months through expedited filing		* '''90-day first payment''' — trust fund claims can be processed in as little as three months through expedited filing

	== Key Facts ~~Box: Mesothelioma Treatment Landscape 2026~~ ==		== Key Facts ==

	{\| style="width:100%~~; border:2px solid #1a5276~~; border-~~radius:8px; margin~~:~~1em 0~~;"		{\| class="wikitable" style="width:100%; border-collapse:collapse;"
	\|-		\|-
	! style="background:#1a5276; color:white; padding:~~15px; font-size:1.1em; text-align:center; border-radius:6px 6px 0 0~~;" \| Key Facts~~: Mesothelioma Treatment Landscape 2026~~		! style="background:#1a5276; color:white; padding:10px;" \| Mesothelioma Treatment Centers Key Facts
	\|-		\|-
	\| style="padding:~~20px~~;" \|		\| style="padding:15px;" \|
	* '''Survival Revolution''': Immunotherapy combinations achieve 41% two-year survival versus 27% with chemotherapy alone		* '''Survival Revolution''': Immunotherapy combinations achieve 41% two-year survival versus 27% with chemotherapy alone
	* '''Surgical Excellence''': Brigham and Women's reports 69.8 months median survival for epithelioid patients with T1 disease		* '''Surgical Excellence''': Brigham and Women's reports 69.8 months median survival for epithelioid patients with T1 disease
Line 413:		Line 406:
	----		----

			<span data-nosnippet class="noai-content">
	{\| style="width:100%; background:linear-gradient(135deg, #ff6b35 0%, #f7931e 100%); border-radius:8px; margin:1em 0;"		{\| style="width:100%; background:linear-gradient(135deg, #ff6b35 0%, #f7931e 100%); border-radius:8px; margin:1em 0;"
	\|-		\|-
Line 426:		Line 420:
	<span style="font-size:0.9em;">No fees unless we recover compensation for you</span>		<span style="font-size:0.9em;">No fees unless we recover compensation for you</span>
	\|}		\|}
			</span>

	----		----

MesotheliomaSupport: Remove H1, add listicle, fix dark mode

2026-02-24T06:41:03Z

Remove H1, add listicle, fix dark mode

Show changes

MesotheliomaSupport: Internal linking: added 9 wiki links

2026-02-20T20:56:03Z

Internal linking: added 9 wiki links

MesotheliomaSupport: Internal linking: added 10 wiki links

2026-02-20T20:46:38Z

Internal linking: added 10 wiki links

← Older revision		Revision as of 20:56, 20 February 2026
Line 35:		Line 35:
	== Executive Summary ==		== Executive Summary ==

	Mesothelioma treatment has undergone revolutionary transformation, with specialized centers now achieving '''41% two-year survival rates''' using immunotherapy combinations—a dramatic improvement from 27% with traditional chemotherapy alone.<ref>[https://www.cancer.gov/types/mesothelioma/patient/mesothelioma-treatment-pdq Mesothelioma Treatment (PDQ)], National Cancer Institute</ref> The United States operates more than 50 specialized mesothelioma treatment facilities, over 70 actively recruiting clinical trials, and an expanding network of VA hospitals dedicated to the approximately '''30% of mesothelioma patients who are military veterans'''. Leading programs at institutions like [[Brigham and Women's Hospital]] report '''median survival exceeding 38 months''' for patients receiving advanced surgical approaches, while CAR-T cell therapy trials at Memorial Sloan Kettering achieve 23.9 months median overall survival.<ref>[https://mesothelioma.net/mesothelioma-treatment-centers/ Mesothelioma Treatment Centers], Mesothelioma.net</ref> This comprehensive guide connects patients and families with specialized treatment resources, financial assistance programs, and qualified legal representation to maximize both medical outcomes and compensation recovery.<ref>[https://dandell.com/mesothelioma-lawyers/ Top-Rated Mesothelioma Lawyers], Danziger & De Llano</ref>		[[Mesothelioma]] treatment has undergone revolutionary transformation, with specialized centers now achieving '''41% two-year survival rates''' using immunotherapy combinations—a dramatic improvement from 27% with traditional chemotherapy alone.<ref>[https://www.cancer.gov/types/mesothelioma/patient/mesothelioma-treatment-pdq Mesothelioma Treatment (PDQ)], National Cancer Institute</ref> The United States operates more than 50 specialized mesothelioma treatment facilities, over 70 actively recruiting clinical trials, and an expanding network of VA hospitals dedicated to the approximately '''30% of mesothelioma patients who are military veterans'''. Leading programs at institutions like [[Brigham and Women's Hospital]] report '''median survival exceeding 38 months''' for patients receiving advanced surgical approaches, while CAR-T cell therapy trials at Memorial Sloan Kettering achieve 23.9 months median overall survival.<ref>[https://mesothelioma.net/mesothelioma-treatment-centers/ Mesothelioma Treatment Centers], Mesothelioma.net</ref> This comprehensive guide connects patients and families with specialized treatment resources, financial assistance programs, and qualified legal representation to maximize both medical outcomes and compensation recovery.<ref>[https://dandell.com/mesothelioma-lawyers/ Top-Rated Mesothelioma Lawyers], Danziger & De Llano</ref>

	== Key Facts Box: Mesothelioma Treatment Landscape 2026 ==		== Key Facts Box: Mesothelioma Treatment Landscape 2026 ==
Line 83:		Line 83:
	=== International Mesothelioma Program at Brigham and Women's Hospital ===		=== International Mesothelioma Program at Brigham and Women's Hospital ===

	The International Mesothelioma Program at Brigham and Women's Hospital in Boston leads globally with approximately '''180 mesothelioma patients treated annually'''. The program achieves remarkable outcomes including '''69.8 months median survival''' for epithelioid histology patients with T1 disease and a '''54.1% five-year survival rate''' for this favorable population. Under Dr. Raphael Bueno's leadership as Chief of the Division of Thoracic Surgery, the center pioneered numerous surgical innovations including the world's first iVATS (image-guided video-assisted thoracic surgery) procedure for mesothelioma.<ref>[https://www.brighamandwomens.org/lung-center/thoracic-surgery/international-mesothelioma-program International Mesothelioma Program], Brigham and Women's Hospital</ref>		The International Mesothelioma Program at [[Brigham and Women's Hospital]] in Boston leads globally with approximately '''180 mesothelioma patients treated annually'''. The program achieves remarkable outcomes including '''69.8 months median survival''' for epithelioid histology patients with T1 disease and a '''54.1% five-year survival rate''' for this favorable population. Under Dr. Raphael Bueno's leadership as Chief of the Division of Thoracic Surgery, the center pioneered numerous surgical innovations including the world's first iVATS (image-guided video-assisted thoracic surgery) procedure for mesothelioma.<ref>[https://www.brighamandwomens.org/lung-center/thoracic-surgery/international-mesothelioma-program International Mesothelioma Program], Brigham and Women's Hospital</ref>

	'''Contact Information:'''		'''Contact Information:'''
Line 153:		Line 153:
	The FDA's September 2024 approval of pembrolizumab with chemotherapy, based on KEYNOTE-483 results showing '''17.3 months median overall survival''', provides another first-line option demonstrating nearly three-fold improvement in response rates. This approval expands [[Treatment Options\|treatment options]] available at community oncology practices, not just specialized centers.<ref>[https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-pemetrexed-and-platinum-chemotherapy-malignant-pleural-mesothelioma FDA Approves Pembrolizumab for Mesothelioma], U.S. Food and Drug Administration</ref>		The FDA's September 2024 approval of pembrolizumab with chemotherapy, based on KEYNOTE-483 results showing '''17.3 months median overall survival''', provides another first-line option demonstrating nearly three-fold improvement in response rates. This approval expands [[Treatment Options\|treatment options]] available at community oncology practices, not just specialized centers.<ref>[https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-pemetrexed-and-platinum-chemotherapy-malignant-pleural-mesothelioma FDA Approves Pembrolizumab for Mesothelioma], U.S. Food and Drug Administration</ref>

	According to Rod De Llano of Danziger & De Llano, "Clinical trial participation represents both a treatment opportunity and documentation opportunity for our clients. The detailed medical records generated during trial participation often strengthen compensation claims by establishing clear causation links between asbestos exposure and disease development."<ref>[https://dandell.com/lawyers/rod-de-llano/ Rod De Llano Attorney Profile], Danziger & De Llano</ref>		According to Rod De Llano of Danziger & De Llano, "Clinical trial participation represents both a treatment opportunity and documentation opportunity for our clients. The detailed medical records generated during trial participation often strengthen compensation claims by establishing clear causation links between [[Asbestos Exposure\|asbestos exposure]] and disease development."<ref>[https://dandell.com/lawyers/rod-de-llano/ Rod De Llano Attorney Profile], Danziger & De Llano</ref>

	----		----
Line 174:		Line 174:
	Specialized centers have refined heated intraoperative chemotherapy approaches that deliver concentrated drug therapy directly to the surgical site:		Specialized centers have refined heated intraoperative chemotherapy approaches that deliver concentrated drug therapy directly to the surgical site:

	'''MD Anderson Cancer Center''': Pioneers in heated chemotherapy for peritoneal mesothelioma, achieving response rates exceeding 40% when combined with optimal cytoreductive surgery.<ref>[https://mesotheliomaattorney.com/mesothelioma/types/peritoneal/ Peritoneal Mesothelioma Guide], MesotheliomaAttorney.com</ref>		'''[[MD Anderson Cancer Center]]''': Pioneers in heated chemotherapy for [[Peritoneal Mesothelioma\|peritoneal mesothelioma]], achieving response rates exceeding 40% when combined with optimal cytoreductive surgery.<ref>[https://mesotheliomaattorney.com/mesothelioma/types/peritoneal/ Peritoneal Mesothelioma Guide], MesotheliomaAttorney.com</ref>

	'''University of Chicago''': Under Dr. Hedy Lee Kindler's leadership, the program integrates HIPEC with immunotherapy for patients with abdominal mesothelioma, demonstrating '''3-5 years median survival''' with complete cytoreduction.		'''University of Chicago''': Under Dr. Hedy Lee Kindler's leadership, the program integrates HIPEC with immunotherapy for patients with abdominal mesothelioma, demonstrating '''3-5 years median survival''' with complete cytoreduction.
Line 194:		Line 194:
	{\| style="width:100%; border:1px solid #28a745; border-left:5px solid #28a745; border-radius:4px; margin:1em 0;"		{\| style="width:100%; border:1px solid #28a745; border-left:5px solid #28a745; border-radius:4px; margin:1em 0;"
	\|-		\|-
	\| style="padding:15px; " \| '''✓ Important:''' Financial assistance through treatment centers is separate from legal compensation. Patients can receive hospital financial aid while simultaneously pursuing asbestos trust fund claims, [[VA Benefits\|VA benefits]], and litigation settlements without any reduction in either funding source.<ref>[https://dandell.com/mesothelioma-compensation/ Mesothelioma Compensation Guide], Danziger & De Llano</ref>		\| style="padding:15px; " \| '''✓ Important:''' Financial assistance through [[Treatment Centers\|treatment centers]] is separate from legal compensation. Patients can receive hospital financial aid while simultaneously pursuing asbestos trust fund claims, [[VA Benefits\|VA benefits]], and litigation settlements without any reduction in either funding source.<ref>[https://dandell.com/mesothelioma-compensation/ Mesothelioma Compensation Guide], Danziger & De Llano</ref>
	\|}		\|}

Line 230:		Line 230:
	• Nationwide telehealth consultations for veterans unable to travel		• Nationwide telehealth consultations for veterans unable to travel
	• Integration with UCLA's comprehensive mesothelioma program		• Integration with UCLA's comprehensive mesothelioma program
	• Coordination with VA benefits claims processing<ref>[https://www.mesotheliomalawyercenter.org/veterans/claims/ Veteran Mesothelioma Claims Guide], Mesothelioma Lawyer Center</ref>		• Coordination with [[VA Benefits\|VA benefits]] claims processing<ref>[https://www.mesotheliomalawyercenter.org/veterans/claims/ Veteran Mesothelioma Claims Guide], Mesothelioma Lawyer Center</ref>

	'''VA Boston Healthcare System''':		'''VA Boston Healthcare System''':
Line 280:		Line 280:
	=== International Centers of Excellence ===		=== International Centers of Excellence ===

	For patients considering international treatment options, several centers demonstrate exceptional mesothelioma outcomes:		For patients considering international [[Treatment Options\|treatment options]], several centers demonstrate exceptional mesothelioma outcomes:

	'''Princess Margaret Cancer Centre''' (Toronto): Dr. Marc de Perrot's SMART protocol (Surgery for Mesothelioma After Radiation Therapy) demonstrates innovative sequencing of radiation and surgery. Fast-track diagnostic procedures minimize treatment delays.		'''Princess Margaret Cancer Centre''' (Toronto): Dr. Marc de Perrot's SMART protocol (Surgery for Mesothelioma After Radiation Therapy) demonstrates innovative sequencing of radiation and surgery. Fast-track diagnostic procedures minimize treatment delays.
Line 299:		Line 299:

	• '''Asbestos Litigation Experience''': Attorneys should have decades of experience specifically with mesothelioma and asbestos cases<ref>[https://www.mesotheliomalawyercenter.org/mesothelioma-lawsuit-asbestos-litigation/ Learn How to File a Mesothelioma Lawsuit], Mesothelioma Lawyer Center</ref>		• '''Asbestos Litigation Experience''': Attorneys should have decades of experience specifically with mesothelioma and asbestos cases<ref>[https://www.mesotheliomalawyercenter.org/mesothelioma-lawsuit-asbestos-litigation/ Learn How to File a Mesothelioma Lawsuit], Mesothelioma Lawyer Center</ref>
	• '''Trust Fund Knowledge''': Understanding of all 60+ active asbestos trust funds and filing requirements<ref>[https://mesotheliomaattorney.com/mesothelioma/trust-funds/ Mesothelioma Trust Funds], MesotheliomaAttorney.com</ref>		• '''Trust Fund Knowledge''': Understanding of all 60+ active asbestos [[Trust Funds\|trust funds]] and filing requirements<ref>[https://mesotheliomaattorney.com/mesothelioma/trust-funds/ Mesothelioma Trust Funds], MesotheliomaAttorney.com</ref>
	• '''Trial Capability''': Willingness and ability to take cases to verdict when necessary		• '''Trial Capability''': Willingness and ability to take cases to verdict when necessary
	• '''Medical Coordination''': Experience working with mesothelioma treatment centers to obtain necessary documentation		• '''Medical Coordination''': Experience working with mesothelioma treatment centers to obtain necessary documentation

← Older revision		Revision as of 20:46, 20 February 2026
Line 11:		Line 11:
	! colspan="2" style="background:#1a5276; color:white; padding:12px; font-size:1.1em; text-align:center;" \| Treatment Center Quick Facts		! colspan="2" style="background:#1a5276; color:white; padding:12px; font-size:1.1em; text-align:center;" \| Treatment Center Quick Facts
	\|-		\|-
	\| colspan="2" style="padding:10px; text-align:center; font-style:italic;" \| Finding the right mesothelioma care		\| colspan="2" style="padding:10px; text-align:center; font-style:italic;" \| Finding the right [[Mesothelioma\|mesothelioma]] care
	\|-		\|-
	\| style="padding:10px; font-weight:bold; width:40%; border-bottom:1px solid #dee2e6;" \| Specialized Centers		\| style="padding:10px; font-weight:bold; width:40%; border-bottom:1px solid #dee2e6;" \| Specialized Centers
Line 35:		Line 35:
	== Executive Summary ==		== Executive Summary ==

	Mesothelioma treatment has undergone revolutionary transformation, with specialized centers now achieving '''41% two-year survival rates''' using immunotherapy combinations—a dramatic improvement from 27% with traditional chemotherapy alone.<ref>[https://www.cancer.gov/types/mesothelioma/patient/mesothelioma-treatment-pdq Mesothelioma Treatment (PDQ)], National Cancer Institute</ref> The United States operates more than 50 specialized mesothelioma treatment facilities, over 70 actively recruiting clinical trials, and an expanding network of VA hospitals dedicated to the approximately '''30% of mesothelioma patients who are military veterans'''. Leading programs at institutions like Brigham and Women's Hospital report '''median survival exceeding 38 months''' for patients receiving advanced surgical approaches, while CAR-T cell therapy trials at Memorial Sloan Kettering achieve 23.9 months median overall survival.<ref>[https://mesothelioma.net/mesothelioma-treatment-centers/ Mesothelioma Treatment Centers], Mesothelioma.net</ref> This comprehensive guide connects patients and families with specialized treatment resources, financial assistance programs, and qualified legal representation to maximize both medical outcomes and compensation recovery.<ref>[https://dandell.com/mesothelioma-lawyers/ Top-Rated Mesothelioma Lawyers], Danziger & De Llano</ref>		Mesothelioma treatment has undergone revolutionary transformation, with specialized centers now achieving '''41% two-year survival rates''' using immunotherapy combinations—a dramatic improvement from 27% with traditional chemotherapy alone.<ref>[https://www.cancer.gov/types/mesothelioma/patient/mesothelioma-treatment-pdq Mesothelioma Treatment (PDQ)], National Cancer Institute</ref> The United States operates more than 50 specialized mesothelioma treatment facilities, over 70 actively recruiting clinical trials, and an expanding network of VA hospitals dedicated to the approximately '''30% of mesothelioma patients who are military veterans'''. Leading programs at institutions like [[Brigham and Women's Hospital]] report '''median survival exceeding 38 months''' for patients receiving advanced surgical approaches, while CAR-T cell therapy trials at Memorial Sloan Kettering achieve 23.9 months median overall survival.<ref>[https://mesothelioma.net/mesothelioma-treatment-centers/ Mesothelioma Treatment Centers], Mesothelioma.net</ref> This comprehensive guide connects patients and families with specialized treatment resources, financial assistance programs, and qualified legal representation to maximize both medical outcomes and compensation recovery.<ref>[https://dandell.com/mesothelioma-lawyers/ Top-Rated Mesothelioma Lawyers], Danziger & De Llano</ref>

	== Key Facts Box: Mesothelioma Treatment Landscape 2026 ==		== Key Facts Box: Mesothelioma Treatment Landscape 2026 ==
Line 60:		Line 60:
	== What Makes a Mesothelioma Treatment Center "Specialized"? ==		== What Makes a Mesothelioma Treatment Center "Specialized"? ==

	The distinction between specialized mesothelioma treatment centers and general oncology programs represents the difference between average outcomes and exceptional survival. Specialized centers treat high volumes of mesothelioma patients annually, maintaining dedicated multidisciplinary teams with thoracic surgeons, medical oncologists, radiation oncologists, pulmonologists, and pathologists who focus specifically on this rare malignancy. Research published in major oncology journals consistently demonstrates that patients treated at high-volume specialized centers experience '''20-40% improved survival''' compared to those receiving care in community settings.<ref>[https://www.cancer.gov/research/nci-role/cancer-centers NCI-Designated Cancer Centers], National Cancer Institute</ref>		The distinction between specialized mesothelioma [[Treatment Centers\|treatment centers]] and general oncology programs represents the difference between average outcomes and exceptional survival. Specialized centers treat high volumes of mesothelioma patients annually, maintaining dedicated multidisciplinary teams with thoracic surgeons, medical oncologists, radiation oncologists, pulmonologists, and pathologists who focus specifically on this rare malignancy. Research published in major oncology journals consistently demonstrates that patients treated at high-volume specialized centers experience '''20-40% improved survival''' compared to those receiving care in community settings.<ref>[https://www.cancer.gov/research/nci-role/cancer-centers NCI-Designated Cancer Centers], National Cancer Institute</ref>

	{\| style="width:100%; border:1px solid #007bff; border-left:5px solid #007bff; border-radius:4px; margin:1em 0;"		{\| style="width:100%; border:1px solid #007bff; border-left:5px solid #007bff; border-radius:4px; margin:1em 0;"
Line 101:		Line 101:
	* Leadership: Dr. Prasad S. Adusumilli and Dr. Marjorie G. Zauderer, Co-Directors		* Leadership: Dr. Prasad S. Adusumilli and Dr. Marjorie G. Zauderer, Co-Directors

	The center's comprehensive pleural and peritoneal mesothelioma programs integrate cutting-edge immunotherapy protocols with surgical expertise.<ref>[https://mesotheliomaattorney.com/mesothelioma/types/pleural/ Pleural Mesothelioma Guide], MesotheliomaAttorney.com</ref> Patients seeking legal representation in New York can coordinate medical treatment with compensation claims through experienced attorneys familiar with the state's court system.<ref>[https://www.mesotheliomalawyercenter.org/mesothelioma-lawyer/new-york/ New York Mesothelioma Attorneys], Mesothelioma Lawyer Center</ref>		The center's comprehensive pleural and [[Peritoneal Mesothelioma\|peritoneal mesothelioma]] programs integrate cutting-edge immunotherapy protocols with surgical expertise.<ref>[https://mesotheliomaattorney.com/mesothelioma/types/pleural/ Pleural Mesothelioma Guide], MesotheliomaAttorney.com</ref> Patients seeking legal representation in New York can coordinate medical treatment with compensation claims through experienced attorneys familiar with the state's court system.<ref>[https://www.mesotheliomalawyercenter.org/mesothelioma-lawyer/new-york/ New York Mesothelioma Attorneys], Mesothelioma Lawyer Center</ref>

	=== MD Anderson Cancer Center ===		=== MD Anderson Cancer Center ===

	MD Anderson Cancer Center in Houston, ranked '''#1 nationally for cancer care for ten consecutive years''', operates a comprehensive mesothelioma program treating hundreds of patients annually through its 30+ member thoracic oncology team. Under Dr. Anne Tsao's direction, MD Anderson has become a leader in immunotherapy research, currently conducting '''16 active mesothelioma clinical trials''' including the pivotal DREAM3R study investigating durvalumab combinations.<ref>[https://www.mdanderson.org/cancer-types/mesothelioma.html Mesothelioma Treatment at MD Anderson], MD Anderson Cancer Center</ref>		[[MD Anderson Cancer Center]] in Houston, ranked '''#1 nationally for cancer care for ten consecutive years''', operates a comprehensive mesothelioma program treating hundreds of patients annually through its 30+ member thoracic oncology team. Under Dr. Anne Tsao's direction, MD Anderson has become a leader in immunotherapy research, currently conducting '''16 active mesothelioma clinical trials''' including the pivotal DREAM3R study investigating durvalumab combinations.<ref>[https://www.mdanderson.org/cancer-types/mesothelioma.html Mesothelioma Treatment at MD Anderson], MD Anderson Cancer Center</ref>

	'''Contact Information:'''		'''Contact Information:'''
Line 126:		Line 126:
	'''UCLA Jonsson Comprehensive Cancer Center''': Dr. Robert Cameron revolutionized lung-sparing surgical approaches and established the West Los Angeles VA Mesothelioma Program serving veterans nationwide. The program demonstrates particular expertise in sarcomatoid mesothelioma, the most aggressive cell type, and offers telemedicine consultations for patients unable to travel. UCLA's approach to epithelioid mesothelioma incorporates the latest surgical innovations with immunotherapy protocols.<ref>[https://www.uclahealth.org/medical-services/lung-cancer/conditions-we-treat/mesothelioma Mesothelioma Treatment at UCLA Health], UCLA Health</ref>		'''UCLA Jonsson Comprehensive Cancer Center''': Dr. Robert Cameron revolutionized lung-sparing surgical approaches and established the West Los Angeles VA Mesothelioma Program serving veterans nationwide. The program demonstrates particular expertise in sarcomatoid mesothelioma, the most aggressive cell type, and offers telemedicine consultations for patients unable to travel. UCLA's approach to epithelioid mesothelioma incorporates the latest surgical innovations with immunotherapy protocols.<ref>[https://www.uclahealth.org/medical-services/lung-cancer/conditions-we-treat/mesothelioma Mesothelioma Treatment at UCLA Health], UCLA Health</ref>

	'''University of Pennsylvania Abramson Cancer Center''': Pioneers in CAR-T cell therapy and photodynamic therapy for mesothelioma, achieving '''31.7-36 months median survival''' with light-activated treatment approaches. The center's proximity to Philadelphia's industrial history serves numerous patients with Pennsylvania asbestos exposure claims.<ref>[https://www.mesotheliomalawyercenter.org/mesothelioma-lawyer/pennsylvania/ Pennsylvania Mesothelioma Attorneys], Mesothelioma Lawyer Center</ref>		'''University of Pennsylvania Abramson Cancer Center''': Pioneers in CAR-T cell therapy and photodynamic therapy for mesothelioma, achieving '''31.7-36 months median survival''' with light-activated treatment approaches. The center's proximity to Philadelphia's industrial history serves numerous patients with Pennsylvania [[Asbestos Exposure\|asbestos exposure]] claims.<ref>[https://www.mesotheliomalawyercenter.org/mesothelioma-lawyer/pennsylvania/ Pennsylvania Mesothelioma Attorneys], Mesothelioma Lawyer Center</ref>

	'''H. Lee Moffitt Cancer Center''' (Tampa): Florida's first NCI comprehensive cancer center treats hundreds of mesothelioma patients annually, achieving '''17.3% five-year survival'''—2.5 times the national average—through integrated multimodal treatment protocols combining surgery, chemotherapy, and radiation therapy.<ref>[https://www.moffitt.org/cancers/mesothelioma/ Mesothelioma Treatment at Moffitt], Moffitt Cancer Center</ref>		'''H. Lee Moffitt Cancer Center''' (Tampa): Florida's first NCI comprehensive cancer center treats hundreds of mesothelioma patients annually, achieving '''17.3% five-year survival'''—2.5 times the national average—through integrated multimodal treatment protocols combining surgery, chemotherapy, and radiation therapy.<ref>[https://www.moffitt.org/cancers/mesothelioma/ Mesothelioma Treatment at Moffitt], Moffitt Cancer Center</ref>
Line 151:		Line 151:
	\|}		\|}

	The FDA's September 2024 approval of pembrolizumab with chemotherapy, based on KEYNOTE-483 results showing '''17.3 months median overall survival''', provides another first-line option demonstrating nearly three-fold improvement in response rates. This approval expands treatment options available at community oncology practices, not just specialized centers.<ref>[https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-pemetrexed-and-platinum-chemotherapy-malignant-pleural-mesothelioma FDA Approves Pembrolizumab for Mesothelioma], U.S. Food and Drug Administration</ref>		The FDA's September 2024 approval of pembrolizumab with chemotherapy, based on KEYNOTE-483 results showing '''17.3 months median overall survival''', provides another first-line option demonstrating nearly three-fold improvement in response rates. This approval expands [[Treatment Options\|treatment options]] available at community oncology practices, not just specialized centers.<ref>[https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-pemetrexed-and-platinum-chemotherapy-malignant-pleural-mesothelioma FDA Approves Pembrolizumab for Mesothelioma], U.S. Food and Drug Administration</ref>

	According to Rod De Llano of Danziger & De Llano, "Clinical trial participation represents both a treatment opportunity and documentation opportunity for our clients. The detailed medical records generated during trial participation often strengthen compensation claims by establishing clear causation links between asbestos exposure and disease development."<ref>[https://dandell.com/lawyers/rod-de-llano/ Rod De Llano Attorney Profile], Danziger & De Llano</ref>		According to Rod De Llano of Danziger & De Llano, "Clinical trial participation represents both a treatment opportunity and documentation opportunity for our clients. The detailed medical records generated during trial participation often strengthen compensation claims by establishing clear causation links between asbestos exposure and disease development."<ref>[https://dandell.com/lawyers/rod-de-llano/ Rod De Llano Attorney Profile], Danziger & De Llano</ref>
Line 194:		Line 194:
	{\| style="width:100%; border:1px solid #28a745; border-left:5px solid #28a745; border-radius:4px; margin:1em 0;"		{\| style="width:100%; border:1px solid #28a745; border-left:5px solid #28a745; border-radius:4px; margin:1em 0;"
	\|-		\|-
	\| style="padding:15px; " \| '''✓ Important:''' Financial assistance through treatment centers is separate from legal compensation. Patients can receive hospital financial aid while simultaneously pursuing asbestos trust fund claims, VA benefits, and litigation settlements without any reduction in either funding source.<ref>[https://dandell.com/mesothelioma-compensation/ Mesothelioma Compensation Guide], Danziger & De Llano</ref>		\| style="padding:15px; " \| '''✓ Important:''' Financial assistance through treatment centers is separate from legal compensation. Patients can receive hospital financial aid while simultaneously pursuing asbestos trust fund claims, [[VA Benefits\|VA benefits]], and litigation settlements without any reduction in either funding source.<ref>[https://dandell.com/mesothelioma-compensation/ Mesothelioma Compensation Guide], Danziger & De Llano</ref>
	\|}		\|}

Line 209:		Line 209:
	Multiple compensation avenues exist to help offset treatment costs and provide financial security for families:<ref>[https://mesotheliomaattorney.com/mesothelioma/compensation/ Mesothelioma Compensation Guide], MesotheliomaAttorney.com</ref>		Multiple compensation avenues exist to help offset treatment costs and provide financial security for families:<ref>[https://mesotheliomaattorney.com/mesothelioma/compensation/ Mesothelioma Compensation Guide], MesotheliomaAttorney.com</ref>

	'''Asbestos Trust Funds''': Over '''$30 billion remains available''' across 60+ active bankruptcy trusts established by former asbestos manufacturers. Average payouts range from $300,000-$400,000, with processing times as quick as 90 days for qualified claims. Trust fund claims can be filed simultaneously with other compensation pursuits.<ref>[https://www.mesotheliomalawyercenter.org/mesothelioma-asbestos-trust-funds/ Asbestos Trust Fund Filing Process], Mesothelioma Lawyer Center</ref>		'''Asbestos [[Trust Funds]]''': Over '''$30 billion remains available''' across 60+ active bankruptcy trusts established by former asbestos manufacturers. Average payouts range from $300,000-$400,000, with processing times as quick as 90 days for qualified claims. Trust fund claims can be filed simultaneously with other compensation pursuits.<ref>[https://www.mesotheliomalawyercenter.org/mesothelioma-asbestos-trust-funds/ Asbestos Trust Fund Filing Process], Mesothelioma Lawyer Center</ref>

	'''Veterans Benefits''': Military veterans with mesothelioma qualify for VA disability compensation up to $4,044.91 monthly for 100% disability rating, plus free VA healthcare at specialized VA mesothelioma centers. The VA recognizes mesothelioma as presumptively service-connected for veterans with documented asbestos exposure.<ref>[https://www.va.gov/disability/eligibility/hazardous-materials-exposure/asbestos/ Asbestos Exposure and VA Disability], U.S. Department of Veterans Affairs</ref>		'''Veterans Benefits''': Military veterans with mesothelioma qualify for VA disability compensation up to $4,044.91 monthly for 100% disability rating, plus free VA healthcare at specialized VA mesothelioma centers. The VA recognizes mesothelioma as presumptively service-connected for veterans with documented asbestos exposure.<ref>[https://www.va.gov/disability/eligibility/hazardous-materials-exposure/asbestos/ Asbestos Exposure and VA Disability], U.S. Department of Veterans Affairs</ref>

	'''Litigation Settlements''': Mesothelioma settlements and verdicts frequently exceed $1 million for cases against solvent defendants. Experienced mesothelioma attorneys work on contingency, meaning no legal fees unless compensation is recovered.<ref>[https://www.mesotheliomalawyercenter.org/largest-mesothelioma-asbestos-settlements/ Mesothelioma Settlements], Mesothelioma Lawyer Center</ref>		'''Litigation Settlements''': [[Mesothelioma Settlements\|Mesothelioma settlements]] and verdicts frequently exceed $1 million for cases against solvent defendants. Experienced mesothelioma attorneys work on contingency, meaning no legal fees unless compensation is recovered.<ref>[https://www.mesotheliomalawyercenter.org/largest-mesothelioma-asbestos-settlements/ Mesothelioma Settlements], Mesothelioma Lawyer Center</ref>

	----		----